However, the overall clinical impact of the ARMS on psychosis prevention in secondary mental health care and the value of using the ARMS designation compared with standard mental diagnoses (eg, those defined by the International Statistical Classification of Diseases and Related Health Problems, Tenth Revision [ICD-10] ) is not completely clear. For example, most individuals meeting ARMS criteria would also meet criteria for a secondary diagnosis of comorbid mental disorder, mostly depression or anxiety. 16 As a result, some authors have claimed that the ARMS construct is not strictly necessary 17 and that psychosis could be predicted (and prevented) within the existing diagnostic categories of common mental disorders. 18 Whether we can pragmatically predict psychosis outside the ARMS designation or not remains unclear because, to our knowledge, no studies have ever addressed this issue. Such a gap of knowledge may have clinical implications for the provision of preventive intervention services and policy makers. In fact, some authors suggest that it would be better to detect and treat psychosis as it emerges from common mental disorders rather than promoting new ARMS services. 18 To further compound the issue, the overall burden of psychosis risk in secondary mental health care is mostly undetermined, and it is not clear whether the ARMS designation is sufficient to pragmatically detect all individuals who will later develop a first episode of psychosis. At Risk Mental State services usually receive referrals on suspicion of psychosis risk, and their referral depends on the subjective judgement of clinicians. Consequently, it is possible that not all individuals in secondary mental health care who will later develop a first episode of psychosis would eventually be detected by ARMS services. This study investigates for the first time, to our knowledge, the proportion of first-episode individuals detected by ARMS services in secondary mental health services as well as the transdiagnostic risk of developing psychotic disorders across any ICD-10-defined mental disorder. The primary aim was to develop and validate a clinically based, practical, individualized risk calculator tool to facilitate the transdiagnostic prediction of psychosis in secondary mental health care and increase the proportion of individuals at risk for psychosis detected by ARMS services to improve outcomes of firstepisode psychosis.
Methods

Data Source
A clinical register-based cohort was selected through a Clinical Record Interactive Search tool 19 (eMethods 1 in the Supplement). The study was registered through http://www .researchregistry.com, study number 1487.
Study Population
All individuals accessing South London and the Maudsley (SLaM) National Health Service Foundation Trust services in the period between January 1, 2008, and December 31, 2015 , and who received a first index primary diagnosis of any nonorganic and nonpsychotic mental disorder were initially considered eligible. We then excluded those who developed psychosis in the 3 months immediately following the first index diagnosis. Approval for the study was granted by the Oxfordshire Research Ethics Committee C. Because the data set comprised deidentified data, informed consent was not required. 19 
Study Measures
The outcome (risk of developing any psychotic disorder), predictors (index diagnosis, age, sex, race/ethnicity, and age by sex interaction), and time to event were automatically extracted using Clinical Record Interactive Search. 19 Predictors were preselected on the basis of previous meta-analytical clinical knowledge, as recommended 20 (eMethods 2 and eTable 1 in the Supplement for full details).
Statistical Analysis
This clinical register-based cohort study was conducted according to the Reporting of Studies Conducted Using Observational Routinely-Collected Health Data Statement 21 (eTable 2 Supplement).
Baseline clinical and sociodemographic characteristics of the sample (including missing data) were described by means and standard deviations for continuous variables, and absolute and relative frequencies for categorical variables. The overall cumulative risk of psychosis onset in SLaM patients was described with the Kaplan-Meier failure function (1-survival) tively compared with the risk of psychosis in the local general population (mean predicted cases across SLaM boroughs, estimated with PsyMaptic [http://www.psymaptic.org/]). 24 Two-sided P values less than .05 were considered significant. Model development and validation followed the guidelines of Royston and Altman, 25 Steyerberg et al, 26 and the Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis. 27 
Model Development
We used Cox proportional hazards multivariable completecase analyses to evaluate the effects of the preselected predictors (index diagnosis, age, sex, race/ethnicity, and age by sex interaction) on the development of nonorganic ICD-10 psychotic disorders and time to development of psychosis, after checking the proportional hazards assumption. 28 Model development was not based on stepwise methods, which are not recommended, 25 but on a priori selection of predictors based on previous knowledge, as detailed in the eMethods 2 in the Supplement. Continuous variables were not dichotomized. 25 Because of significant sociodemographic differences between the SLaM boroughs, 29 we used nonrandom split-sample development and external validation, 27 with the Lambeth and Southwark cases in the derivation sample and all other cases in the validation sample. The model with all preselected predictors was first fitted to the derivation data to estimate the optimal regression coefficients. Performance diagnostics of individual predictor variables in the derivation data set were explored with Harrell C index, 25 which is similar to the area under the receiver operating characteristic curve. We then generated individual prognostic scores, allowing a prognostic index for risk of psychosis onset to be developed in the derivation data set. 30 As a supplementary analysis, we fitted the model after excluding the acute and transient psychotic disorder cases.
External Model Validation
The regression coefficients as estimated in the derivation data set were then applied to each case in the external validation data set to generate the prognostic index in the validation data set. Overall model performance (the distance between the predicted outcome and actual outcome 26 ) was assessed with the Brier score (the average mean squared difference between predicted probabilities and actual outcomes, which also captures calibration and discrimination aspects). 26 A lower score indicates higher precision and less bias, but interpretation depends on the incidence of the outcome. 26 Overall performance was further investigated with the Royston modification of the Nagelkerke R 2 (indexing the proportion of variation explained by the model). 31 Calibration (the agreement between observed outcomes and predictions 26 ) was assessed with the regression slope of prognostic index 26 (which also captures discrimination and model fit), 25 with the regression intercept (calibration in the large, 26 estimated as previously detailed 32 ) and with the calibration plot (resampling model calibration with hare function). 33 Discrimination (accurate predictions discriminate between those with and those without the outcome 26 ) was addressed with Harrell C index 25 and with the discrimination slope (difference in mean of predictions between outcomes). 26 Studies indicate that unbiased and precise estimation of performance measures can be achieved with a minimum of 100 events in the external validation data set. 
Results
Sociodemographic and Clinical Characteristics of the Sample
Of 92 227 patients receiving a first index diagnosis of nonorganic and nonpsychotic mental disorder within SLaM in the period between 2008 and 2015, 91 199 fulfilled the study inclusion criteria and were included in the derivation or validation data sets, as indicated in Figure 1 . Table 1 shows the baseline characteristics of the study population, as well as the derivation and validation data sets. As expected, there were significant sociodemographic differences across the derivation and validation data sets (Table 1) , particularly with respect to race/ethnicity and index diagnosis. The mean follow-up was 1588 days (95% CI, 1582-1595), with no differences between the derivation and validation data sets (derivation: mean, 1589; 95% CI, 1579-1599; validation: mean, 1588; 95% CI, 1580-1596). The overall 6-year risk of developing a psychotic disorder was 3.02 (95% CI, 2.88-3.15) and higher than the 6-year risk of psychosis of 0.62 in the local general population (eResults 1 and eFigure 1 in the Supplement). The baseline hazard function is reported in eFigure 2 in the Supplement.
Model Development
In the derivation data set, there were 1001 transitions to psychosis (52 of which were observed in the ARMS construct [5.19%] , eTable 3 in the Supplement). The multivariable model significantly predicted psychosis onset (likelihood ratio χ 2 test, 1767.59; P < .001). Age and male sex were significantly associated with an increased risk of psychosis ( Table 2) . Across men, risk of psychosis decreased with increasing age (Table 2) . Relative to white race/ethnicity, black, Asian, mixed, and other races/ethnicities were associated with an increased risk of developing psychosis (Table 2) . Compared with the reference ARMS designation, all of the other ICD-10 mental disorders were associated with a lower risk of developing psychosis, with 2 exceptions (Table 2) . Bipolar mood disorders and acute and transient psychotic disorders showed a comparable and higher risk of psychosis than the ARMS construct, respectively ( Table 2 . The model showed very good overall apparent performance (good discrimination, C index, 0.80) and explained approximately 75% of the observed variation ( Table 3) . The model remained significant after removing the acute and transient psychotic disorder cases (eTable 4 in the Supplement).
Model Validation
In the external validation data set there were 1010 transitions to psychosis (12 of which were observed in the ARMS [1.19%] ; eTable 3 in the Supplement), a value that greatly exceeds the minimum of 100 events required for robust external validation. 34 The model retained an overall good performance and was able to explain around 72% of the observed heterogeneity (Table 3) . Model discrimination was fair to good, with a C index of 0.79 (Table 3 ). The mean risk of psychosis in the validation data set was lower than in the derivation data set, but there were no major miscalibration issues (Table 3 ; eFigure 3 in the Supplement).
Potential Clinical Usefulness of the Risk Calculator
At the reference threshold for recommending focused interventions to prevent psychosis, the use of the model was associated with significant net benefits in both the derivation and validation data sets ( Table 3 ). The decision curve estimated in the validation data set ( Figure 2 ) shows that compared with conducting no tests, testing on the basis of the risk calculator is associated with net benefits for a 1% to 50% range of threshold probability (risk of developing psychosis by 5 years; eResults 2 in the Supplement). An online version of the risk calculator was built to facilitate numeric calculation of the predicted probability of con- version to psychosis in secondary mental health care (http: //www.psychosis-risk.net).
Discussion
A total of 91 199 patients receiving a first index diagnosis of nonorganic and nonpsychotic mental disorder within SLaM were included in the study, either in the derivation (33 820) or validation (54 716) data sets, with a mean follow-up of 1588 days. The overall 6-year risk of psychosis in secondary mental health care was 3.02 (95% CI, 2.88-3.15) and was higher than the 6-year risk of psychosis in the local general population (0.62). Compared with the ARMS designation, all of the other ICD-10 diagnoses were associated with a lower risk of psychosis, with 2 exceptions. Bipolar mood disorders and acute and transient psychotic disorders showed a similar and higher risk of psychosis than the ARMS, respectively. The ARMS designation accounted only for a small proportion of transitions to psychosis (n = 52 of 1001; 5.19%), indicating the need for transdiagnostic prediction of psychosis in secondary mental health care. The prognostic risk stratification model based on preselected clinically based variables (index diagnosis, age, sex, age by sex, and race/ethnicity) showed good prognostic accuracy in the derivation data set. The risk calculator was externally validated, confirming good performance and potential clinical usefulness for the transdiagnostic prediction of psychosis in secondary mental health care. This study has 3 significant clinical implications. First, we confirmed substantial psychosis risk enrichment in individuals accessing secondary mental health care. The 6-year risk of psychosis was 5-fold higher than in the local general population (3.02/ 0.62 = 4.87) and in individuals accessing primary care, 37 highlighting a clear window of opportunity for the transdiagnostic prevention of psychosis within secondary mental health care. 38 Second, we have shown that the ARMS designation, in particular its attenuated psychotic symptoms subgroup (footnotes to Table 2 ), is necessary to predict psychosis in individuals who have never experienced psychotic (eg, brief limited intermittent psychotic symptoms 39 ) symptoms. The ICD-10 categories of substance use disorders, nonbipolar mood disorders, anxiety disorders, personality disorders, developmental disorders, childhood/adolescence onset disorders, physiological syndromes, and mental retardation showed a lower level of psychosis risk. Accordingly, the use of ICD-10 categories of comorbid mental disorders, such as anxiety or depression, is unlikely to be of any clinical usefulness to predict psychosis. The ICD-10 acute and transient psychotic disorders and the brief limited intermittent psychotic symptoms subgroup of the ARMS were both associated with a very high risk of developing psychosis, in particular schizophrenia spectrum psychoses, but only in individuals with remitting symptoms at the time of the index diagnosis.
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Similarly, bipolar mood disorders specifically predicted the onset of affective spectrum psychoses.
Third, we have demonstrated that the ARMS designation, although necessary, is not sufficient to intercept the overall burden of psychosis risk in secondary mental health care (eDiscussion 1 in the Supplement). In fact, although Outreach and Support in South London was established in Lambeth and Southwark several years before the start of the current cohort, 42 only 314 of 33 820 individuals (0.93%) were receiving Outreach and Support in South London care, accounting for only 5.19% of the total cases of emerging psychosis across the 2 boroughs. More importantly, none of the patients outside of Outreach and Support in South London care had ever been assessed for an ARMS. This seems like a missed clinical opportunity because screening for an ARMS is specifically indicated for individuals "already distressed by mental problems" 43 and accessing secondary mental health care, 44 to prevent psychosis with indicated interventions, 13 and improve outcomes in those who go on to develop psychosis (by reducing the duration of untreated psychosis, admission to hospital, and compulsory treatments 45 or unnecessary treatment).
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Building on the aforementioned points, our findings highlight a significant unmet need for transdiagnostic prevention of )
. The risk calculator was implemented online and designed to generate a number representing the probability of transition to psychosis, given a particular profile of input variables. A key advantage of the risk calculator is that it inherently accommodates heterogeneity in profiles of risk factors among high-risk individuals. 47, 48 At the same time, the risk calculator assumes that individuals have accessed secondary mental health care and that the predictor variables are coded as indicated in our methods (eg, ICD-10 categories for the index diagnosis). Therefore, the risk prediction tool would not be usable in primary care or the general population, or if other diagnostic criteria have been used (eg, DSM). This tool is therefore most useful to clinicians using the calculator for patients who have accessed secondary mental health services. The online calculator could also be easily integrated into electronic case registers, such as the Clinical Record Interactive Search, to facilitate the automatic and individualized prediction of psychosis. Critically, risk determinations should be communicated to patients by clinicians who can help patients understand the meaning of the risk estimates and provide commensurate treatment recommendations. The decision curve analysis presented in our study can further help clinicians to tailor individualized focused interventions, such as selecting patients to be referred to ARMS services. Focused interventions may include a detailed clinical assessment for psychosis risk (ie, the ARMS assessment) combined with sequential testing, 49, 50 close-in clinical monitoring for the emergence of psychosis, and psychological treatments recommended to prevent psychosis. Future studies are needed to refine the focused interventions targeting the high-risk individuals detected by our risk calculator. It is also possible that not all high-risk individuals, even when properly referred and assessed, would eventually meet ARMS criteria. For example, research in high-risk individuals with an index diagnosis of bipolar disorders may help to refine the ARMS construct and its ability to predict the onset of affective psychoses. 51 Similarly, the effectiveness of preventive psychological treatments in individuals deemed at risk by our calculator but not meeting ARMS criteria should be further investigated.
Limitations
Limitations of this study are addressed in eDiscussion 2 of the Supplement and primarily involve the use of a clinical case register database that shows high ecological validity but lack of formal validation with research-based criteria. Furthermore, the transportability of our model to different clinical scenarios should be confirmed and refined by external replication studies.
Conclusions
Individuals accessing secondary mental health services are at enhanced risk of developing psychosis compared with the local general population. The use of this novel individualized risk calculator can be of clinical usefulness to improve the transdiagnostic detection of at-risk individuals and prevention of psychosis in secondary mental health care. 
Predictors
Univariate screening and/or stepwise predictor selections have been criticized on multiple grounds. 12 Conversely, Steyerberg et al 13 recommend that: "predictor selection should usually consider clinical knowledge and previous studies rather than solely rely on statistical selection methods". A recent methodological review of predictive studies in individuals at clinical high risk for psychosis specifically recommended that candidate predictors could be selected on the basis of existing metaanalytical knowledge. 12. In line with these recommendations and in order to meet the objective of developing a practical tool for risk prediction, our focus was on a few preselected demographic and clinical measures that are easily collected in general clinical settings. The number of predictors was further limited to five, to ensure that there was a high event per variable (EPV>20) ratio, which is recommended to develop robust models in the case of relatively infrequent outcomes. 14 The data in the current study were not used to select the predictors, as described in more detail below.
The rationale for selecting the index diagnosis as the key a-priori predictor of interest was detailed in Psychosis-Risk Syndrome (SIPS; for details on these competing operationalizations see Table 1 that was published in Fusar-Poli et al 15 and previous publications on the diagnostic and prognostic significance of BLIPS 15, 16 ) . On a diagnostic level, about two thirds (68%) of BLIPS meet ATPD criteria, 16 while the proportion of ATPD meeting BLIPS criteria is unknown. We included the ATPD to conceptually match the ARMS construct which is used to predict both first episode of psychosis (in patients meeting APS) and a psychotic relapse (in patients meeting the BLIPS criteria). 16 We recently suggested overcoming these discrepancies with a revised model of the ARMS that is based on the clinical staging of APS vs BLIPS subgroups. [17] [18] [19] [20] [21] the ARMS designation was additionally deconstructed into its three subgroups (eTable 1).
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The other predictors were selected on the basis of an established empirical link to psychosis risk, as supported by at least one previous meta-analysis. There was no attempt to select predictors based on theoretical causal models of psychosis, clinical knowledge or intuition. The preselected predictors included age, 28 gender, 28 ethnicity, 28 and age by gender interaction, 28 which were found to be reliably associated with an increased incidence of psychotic disorders in a large meta-analytical sample (83 studies) of people aged 16-64. 28 The predictors extracted from the electronic records were those recorded closest to the time of first contact with SLaM.
Time to event
The follow-up began three months after the date of the index diagnosis within SLaM, censored at 1 st April 2016. This lag period was chosen to allow patients sufficient time after their index diagnosis to meet the ICD-10 duration criterion for acute and transient psychotic disorders (F23.x). Since we did not employ a structured assessment at baseline (see limitations), this lag period was also used to be conservative and exclude individuals who were underreporting psychotic symptoms at baseline (false eTable 1. Primary index diagnoses of non-organic and non-psychotic mental disorder Diagnostic group ICD-10 code ICD-10 diagnosis name ARMS APS (1) At Risk Mental State, Attenuated Psychosis Syndrome Subgroup BLIPS (1) At Risk Mental State, Brief and Limited Intermittent Psychotic Symptoms GRD (1) At Risk Mental State, Genetic Risk and Deterioration syndrome Acute and transient psychotic disorders
F23.x
Acute and transient psychotic disorders
Substance use disorders F10 (excluding *.5, *.4, *.7) Non psychotic mental and behavioural disorders due to use of alcohol F11 (excluding *.5, *.4, *.7)
Non psychotic mental and behavioural disorders due to use of opioids F12 (excluding *.5, *.4, *.7)
Non psychotic mental and behavioural disorders due to use of cannabinoids F13 (excluding *.5, *.4, *.7)
Non psychotic mental and behavioural disorders due to use of sedatives or hypnotics F14 (excluding *.5, *.4, *.7)
Non psychotic mental and behavioural disorders due to use of cocaine F15 (excluding *.5, *.4, *.7)
Non psychotic mental and behavioural disorders due to use of other stimulants, including caffeine F16 (excluding *.5, *.4, *.7)
Non psychotic mental and behavioural disorders due to use of hallucinogens F17 (excluding *.5, *.4, *.7)
Non psychotic mental and behavioural disorders due to use of tobacco F18 (excluding *.5, *.4, *.7)
Non psychotic mental and behavioural disorders due to use of volatile solvents F19 (excluding *.5, *.4, *.7)
Non psychotic mental and behavioural disorders due to multiple drug use and use of other psychoactive substances Bipolar mood disorders F31. Unspecified mental retardation F00-F09 organic mental disorders and all psychotic disorders other than F23.x were excluded; (1) ICD-10 codes not applicable. Subjects meeting multiple ARMS criteria were stratified for symptom severity as previously suggested 26 : any BLIPS>APS or APS+GRD>GRD alone.
eMethods 3. Exchange rate and decision curve analysis
The exchange rate can be qualitatively derived by asking simple questions, such as the maximum number of ARMS patients that a doctor would recommend for focused interventions (encompassing clinical assessment, close-in monitoring, and psychological therapies) 27 to prevent one patient developing the outcome. In ARMS patients, the meta-analytical number needed to treat is 14. 30 This implies that the harm of delaying focused interventions for psychosis prevention is 13 times greater than that of an unnecessary treatment (among 14 patients undergoing focused interventions, one psychosis prevented equates to 13 unnecessary treatments). We thus used 1/13=7.69% as an approximate exchange rate. However, as the answers to these kinds of questions and the exchange rates are subjective, we additionally plotted net benefit for a range of reasonable exchange rates in a decision curve analysis. Descriptive data 14 (a) Give characteristics of study participants (e.g., demographic, clinical, social) and information 
eResults 2. Net benefit analysis
For example, the net benefit of 0.013 at a threshold probability of 10% (as reported in Figure 2 ),
indicates that compared to conducting no tests, testing on the basis of the risk calculator is equivalent to a strategy that found 1.3 patients at risk for psychosis per hundred patients, without conducting any unnecessary testing.
eFigure 2 Smoothed curve of the baseline hazard function in the derivation database using kernel density estimation. 33 Since April 2016, all early intervention for psychosis services are required to assess for the presence of an ARMS. Although the Standard is likely to increase the number of sites that will detect ARMS in England, there is no guarantee that it will improve the detection of individuals at risk of psychosis within each NHS Trust. It is clear that the clinical utility of the ARMS for improving the outcomes of first episode psychosis is not only dependent on its prognostic validity and on the availability of effective preventative treatments but also on its ability to be pragmatically implemented in order to detect the vast majority of individuals who will later develop psychosis. There is limited evidence on the latter point and, to our knowledge, our manuscript is the first to address the overall impact of a well-established ARMS service (with more than 10 years implementation history) on the detection of first episode cases. We showed that even well established ARMS services can pragmatically detect only about 5% of the total individuals later transitioning to psychosis. Such a number could be used as reference threshold to measure the impact of the AWT Standard in the near future. More importantly, our tool has been developed to facilitate the detection of individuals at risk of psychosis and promote their referrals to ARMS services, thereby increasing the ability of ARMS services to detect individuals at risk of psychosis in secondary mental health care. The use of our calculator is clinically meaningful over competing detection strategies such as detecting only those referred on suspicion of psychosis risk (current practice, only 5% of first-episode cases detected), or assessing all 91,199 patients accessing secondary mental health services (a strategy that is impracticable because of logistic and socioeconomic difficulties). These different detection possibilities are summarized by our decision curve analysis that is plotted in Figure 2 .
eDiscussion 2. Strengths and weaknesses of the study
To the best of our knowledge, this is the first study to explore the transdiagnostic risk of psychosis across all ICD-10 mental disorders compared to the ARMS. Additional methodological strengths include the use of a large-scale database indexing real-world outcomes with a long-term follow-up, and the use of robust external validation 34 following international guidelines. Building on these strengths, we were able to produce a practical, individualized online risk calculator tool which requires few input variables (that are easily and routinely collected), and is therefore suited to use in clinical practice.
At the same time, we did not employ structured psychometric interviews to ascertain the type of emerging psychotic diagnoses at follow-up and their diagnostic stability. 35 Therefore, while the psychotic diagnoses in our database are high in ecological validity (i.e. they represent real-world clinical practice), they have not been subjected to formal validation with research-based criteria.
However, as previously noted in at-risk samples, 36 the use of structured diagnostic interviews can lead to selection of patient subsamples and introduce additional biases. Furthermore, there is also metaanalytical evidence indicating that for psychotic categories, administrative data recorded in clinical registers are generally predictive of true diagnosis. 37 These issues have been fully detailed in our previous CRIS-related publication. 6 Another limitation is that secondary mental health services are heterogeneous. The transportability of our model to different clinical scenarios 38 should therefore be confirmed and refined by external replication studies. To facilitate this, we have provided the required statistical information (e.g. Table 2 , Table 3 ) as recommended by international guidelines. 39 
